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Twenty-three sequences from the family of G-protein coupled receptors have been aligned according to the ‘historical 
alignment’ procedure of Feng and Doolittle. Fourier transform analysis of this reveals that parts of five of the seven 
putative membrane-spanning regions exhibit a periodicity of conserved/nonconserved r sidues which is compatible with 
the periodicity of the a-helix. This would place the conserved residues on one side of the helix, which may face the inside 
of the proposed seven membered helical bundle. 
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1. INTRODUCTION 
Receptors linked to second messenger produc- 
tion through guanine nucleotide-binding regulato- 
ry proteins (G-proteins) are fast becoming one of 
the most important receptor systems discovered to 
date. The incredible diversity of the ligands which 
bind to these receptors and the equally diverse na- 
ture of the cellular effects of this binding are sur- 
prisingly complemented by a high degree of se- 
quence homology in the receptors themselves, espe- 
cially in the seven proposed hydrophobic regions 
([1] for review). 
Secondary structure predictions and hydro- 
phobicity and hydrophobic moment plots predict 
seven transmembrane helices and give similar re- 
sults for the different classes of these receptors ug- 
gesting a similar topology throughout the family 
[2-61. The proposed transmembrane topologies of 
these proteins consist of a helical bundle containing 
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seven transmembrane helices arranged in a similar 
fashion to the low-resolution electron density map 
of bacteriorhodopsin [7]. Spectral evidence [8-121 
suggests that this comparison is justified despite 
the lack of sequence homology between the pro- 
karyotic and eukaryotic proteins. Protease protec- 
tion and chemical probe experiments have deter- 
mined the location of individual residues relative to 
the membrane [13-241. Information on the disposi- 
tion of amino acid residues in the transmembrane 
segments was obtained using a photoactivated 
nitrene-generating hydrophobic probe which iden- 
tified 20 nucleophilic sidechains of ovine rhodopsin 
exposed to the lipid domain [25,26]. 
X-ray analysis of crystals of the reaction centre 
from Rhodopseudomonas viridis allowed the cal- 
culation of an electron-density map at 3 A resolu- 
tion [27,28]. The structure of the Rhodobacter 
sphaeroides reaction centre was later determined to 
a resolution of 2.8 A [29-331. This system repre- 
sents the only high-resolution structure of an in- 
tegral membrane protein. Sequence alignments and 
Fourier transform analysis of the periodicity of 
conserved/nonconserved redisues have recently 
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been described for the reaction centre [34]. This 
analysis shows that the conserved residues in cer- 
tain helices exhibit a periodicity which is compati- 
ble with them being on one side of an a-helix. 
These helices are on the surface of the reaction cen- 
tre. Analysis of integral membrane proteins has 
shown that surface residues are poorly conserved 
[3 I]. Hence helices which are on the surface of pro- 
teins should have a conserved internal facing side 
and a variable external side (facing the lipid) and 
we refer to these helices as amphipathic. 
We propose a model for the G-protein coupled 
receptors based solely on the multiple alignment of 
the sequences from 23 receptors in this class. The 
method is based on the analysis of the periodicity 
of conserved residues in the putative transmem- 
brane regions following the principle outlined 
above [34]. The proposed seven membered helical 
bundle [ 1,7] of these proteins provides the possibil- 
ity that all seven helices may have a conserved in- 
ternal face and a variable external surface. This 
method may thus be useful in the modelling of 
these receptors. 
2. METHODS 
Sequence alignments were carried out on 23 different se- 
quences of G-protein coupled receptors. The multiple alignment 
of the sequences was obtained with the ‘historical alignment’ 
procedure of Feng and Doolittle [35]. In this procedure se- 
quences are incorporated into the multiple alignment according 
to the topology of an initial phylogenetic tree constructed on the 
basis of pairwise alignments and the distance metric of Feng et 
al. [36]. 
The sequences used [37-531 were the muscarinic cholinergic 
receptors (human subtypes Ml, M2, M3, M4, M5, rat subtypes 
Ml, M2, M3, M4, M5, and porcine subtypes Ml, M2), (Y- 
adrenergic receptor (human kidney), ,&adrenergic receptors 
(human @l and /32, avian ,81, hamster ,82), SHT-IA receptor 
(human), SHT-1C receptor (rat), 5HT-2 receptor (rat), the D2 
dopamine receptor (rat), bovine substance K receptor and 
bovine rhodopsin. 
The extent of the helical regions in this analysis (fig.6) was 
based on the model of ovine rhodopsin [7] and on hydro- 
phobicity studies, with the condition that the 23 sequences used 
aligned well in these regions. Single residue deletions and inser- 
tions in the alignment which occurred in these helical regions 
were adjusted so that an equal number of sequential residues 
was compared. This is necessary if regular helices are to be 
presumed. Gaps and insertions occurred in the centre of helix 2 
and helix 4, at the N-terminus of helix 1 and at the C-terminus 
of helix 4 and helix 6. There were no occurrences of insertions 
or deletions of more than one residue. 
Fourier transform analysis was carried out on these regions as 
previously described for the reaction centre [34]. The power 
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spectra P(w) may be defined as 
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where Vj, the number of different amino acids at each position 
in the sequence alignment; Vj, the mean value of Vj; w, the rota- 
tion angle between adjacent residues in the helix; j, the position 
of the amino acids in the helix. The plot of P(W) against w gives 
a value of urnax at about 100”. 
The number of residues preferentially conserved on one side 
of the helix can be characterized by 4 where 
and represents the average value of P(w) in the cu-helical region 
(w = 90-120”). A value of greater than 2 was taken as a sign of 
an amphiphatic helix [34]. 
The conservancy at each position can also be defined as C 
where C = z/Vj (z = the number of sequences used in the align- 
ment). C can be plotted as a helical wheel to show pictorially the 
amphipathic nature of the helix (fig.3a). The value of urnax is us- 
ed in this plot to show the maximum periodicity so long as it is 
compatible with an a-helical conformation, that is between 3.4 
and 3.6 residues per turn. The heavy arrow represents a moment 
of conservancy and is the sum of the individual vectors cal- 
culated from C(w) where 
[ 
N 2 
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N 
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The helical plot however does not show at which vertical 
points in the putative helix the conservancy occurs. This can be 
seen by plotting the most conserved 160” of the helical wheel on 
one side of a ‘helical rod’ (fig.3b) and the remaining variable 
region on the opposite side. The actual length of the amphi- 
pathic regions in the putative helix can then be appreciated and 
P(w), C(w) and + can be recalculated for each of these amphi- 
pathic regions. 
3. RESULTS AND DISCUSSION 
Fig.la shows the alignment of the first hydro- 
phobic region with all insertions and deletions 
removed and fig.lb shows the variance across this 
helical region. The Fourier transform of this (fig.2) 
shows a peak at about 105” which corresponds to 
a periodicity of approximately 3.4 residues per turn 
which is compatible with an a-helical conforma- 
tion. 
The surface residues of globular and integral 
membrane proteins are less conserved than those 
buried in the centre. A peripheral a-helix is exposed 
to both the inside and the outside of a protein and 
hence we would expect a periodicity of conservancy 
corresponding to the number of residues per turn 
of the helix. The normalized area of the peak, +, 
provides a measure of the exposure of the helix of 
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Fig. 1. (a) Alignment for the sequences corresponding to helix 1. Vj corresponds to the number of different residue types at each position. 
The conserved asparagine is indicated with an underscore. The sequences used are the muscarinic cholinergic receptors (human sub- 
types, MR HMl - MR HM5, rat subtypes RAT Ml - RAT MS, and porcine subtypes PIG Ml and PIG M2), human (~2 adrenergic 
receptor (HAZAR), ,LY adrenergic receptors (human subtypes Bl HUM and B2 HUM, avian BAR AVI, hamster B2 HAM), SHT-IA 
receptor (human), 5HT-1C receptor (rat), 5HT-2 receptor (rat), the D2 dopamine receptor (rat), bovine substance K receptor (SKRBOV) 
and bovine rhodopsin (RHBOV). (b) The plot of Vj against residue number 0) for helix 1 shows how the conservancy varies over the 
putative transmembrane r gion. 
an integral membrane protein to the membrane as 
previously described for the reaction centre. The 
calculated values of # for helices A and B of the 
reaction centre are 2.5 for each helix. The values 
for the seven helices of the G-protein coupled 
receptors are summarised in table 1. 
The helical plot of conservancy for helix 1 
(fig.3a) shows pictorially the amphipathic nature 
of the helix. The vertical plot (fig.3b) shows that 
the C-terminal end of the first helix is much more 
amphipathic than the N-terminal end. The Fourier 
transform of the most amphipathic section of each 
helix (16 residues) (fig.4) results in a value of &, 
greater than 2 for six of the seven helical regions 
(table 1) suggesting that the amphipathicity is more 
pronounced in these sections of helix. 
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Fig.2. The Fourier transform spectrum P(W) for the first trans- 
membrane region (33 residues). The peak at 105” corresponds to 
a periodicity of about 3.4 residues per turn. The normalised area 
of the peak + gives a value of 2.2, which is indicative of an am- 
phipathic helix. 
Although the value of & of helix 7 is 3.1, the 
Fourier transform plot of this region (not shown) 
shows a broad peak at 84” and another at 114” 
which result in this high value of $16, even though 
there is actually a trough at 100”. The helical wheel 
plot of this helix using 3.4 residues per turn (fig.5) 
does however show that the helix has a more con- 
served side. However the vertical plot (fig.6) shows 
that the sequence corresponding to L-C-Y(407)-V- 
N-S-T-I does not show amphipathic character. 
Coupled with the unusual Fourier transform plot, 
this may reflect the presence of the distorted region 
predicted previously in rhodopsins in the region of 
Table 1 
Values of $ calculated for the 7 helices of the G-protein complex 
receptors 
Helix No. of residues 
per helix 
(L $16 Residues per turn 
used in the 
helical wheels 
1 33 2.2 2.6 3.4 
2 29 1.1 1.9 3.4 
3 32 2.1 3.6 3.6 
4 26 2.7 3.5 3.4 
5 33 2.4 2.7 3.6 
6 34 1.7 2.7 3.6 
7 22 1.9 3.1 3.4 
The number of residues per turn used in the helical wheels was 
taken from urnax between 100” and 106”. $ reflects the preferen- 
tial conservation of residues on one side of the helix. #16 refers 
to $ calculated over a 16 residue length of sequence which shows 
the most amphipathicity. Values of & and $16 which are greater 
than 2 reflect a high probability of an amphipathic helix over the 
length of the sequence used 
Fig.3. (a) The helical wheel depiction of the amphipathicity of 
helix 1. The conservancy C is taken as Z/Vj where z is the 
number of sequences used in the analysis. The heavy line is the 
sum of the individual vectors and points to the interior of the 
helical bundle. The rotation angle (w) is urnax from the Fourier 
transform (fig.2) and in this case is about 105”. (b) The vertical 
plot representation of the amphipathicity of helix 1. The se- 
quence given refers to the Ml subtype of the human muscarinic 
cholinergic receptor. The right side of the plot represents the 
most conserved 160” of the helical wheel plot (depicted in a). It 
clearly shows that the amphipathicity of helix 1 is confined to 
the carboxy-terminal region of the putative membrane spanning 
region, that is the cytoplasmic end. 
the retinal binding domain [2,3,7]. The equivalent 
position to the retinal binding lysine of bovine op- 
sin in our alignment is the Y-407 in the human Ml 
subtype of the muscarinic cholinergic receptor. 
The Fourier transform plot of helix 2 shows a 
broad peak over the helical region and does not 
WOO 
1 
Fig.4. The Fourier transform of the 16 residues at the carboxy- 
terminal end of helix 1 shows a similar peak at 105”. The value 
of $16 in this case is 2.6 showing a greater degree of am- 
phipathicity in this region of the first membrane spanning 
region. 
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Fig.5. The helical wheel depiction of all seven helical regions arranged as if viewed from the extracellular side of the membrane. The 
helical bundle is arranged according to the seven high density regions of the electron density map of bacteriorhodopsin as described 
previously [7]. The membrane spanning regions are depicted so that the conserved side of each helix points towards the centre of the 
helical bundle. 
show any convincing periodicity. This may have 
implications for its three-dimensional structure 
suggesting that this region is either not a regular 
helix or that it is not a peripheral helix. 
The Fourier transform spectra for the sixteen 
residue sections of helices 1, 3, 4, 5 and 6 show a 
strong periodicity which is compatible with an cy- 
helical conformation. We propose that the con- 
served side of these helices faces the interior of the 
helical bundle (fig.5) and that these regions have a 
regular helical structure. Since a helix of at least 
20-22 residues is required to cross the membrane 
we suggest hat the 16 residue sections which con- 
stitute the more amphipathic regions of the mem- 
brane spanning helices reside at a similar depth in 
the membrane (fig.6) and constitute a conserved 
core which is involved in helix packing and ligand 
binding. 
This model can be compared with more ex- 
perimental results on the disposition of amino acid 
residues in the transmembrane regions. Studies on 
the ,&adrenergic receptor have revealed that two 
aspartate residues were critically important in 
ligand binding [55,56]. The equivalent residues in 
the human Ml muscarinic cholinergic subtype are 
D-71 and D-105 which reside in helices two and 
three, respectively. Our model places these residues 
on the inside of the helical bundle where the ligand 
is believed to bind. A third aspartate residue, D-122 
on the cytoplasmic side of the third putative helix, 
may also be involved in ligand binding. However 
we find that this aspartate lies 120” from the vector 
sum of conserved residues. The sequence alignment 
of the third putative helical region is shown in 
fig.7. 
The equivalent residue to the retinal binding 
lysine of bovine opsin is Y-407 and this too is found 
to reside on the inside of the helical bundle though 
as mentioned above, this region may not have a 
regular helical conformation. 
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EXTRACELLULAR SIDE 
Fig.6. The vertical plots of all seven predicted membrane spanning regions arranged in an anti-parallel fashion as is believed to be the 
case in the helical bundle. The cytoplasmic side of the helical bundle is represented on the bottom of the diagram and the extracellular 
side on the top. The conserved side of the helix is depicted on the right hand side of the sequence of the human muscarinic holinergic 
receptor subtype Ml. 
Other experimental studies on the disposition of 
amino acid residues in the helices include ex- 
periments in which a photoactivated nitrene- 
generating probe was used to selectively label 
residues on the outside of the helical bundle 
[7,25,26]. Our analysis is 60-65% compatible with 
these results. By definition, our method places the 
conserved residues, such as the conserved tryp- 
tophans in helices 4 and 6 and the conserved 
tyrosine of helix 5, on the inside of the helical bun- 
dle despite evidence that they face the lipid environ- 
ment [7,25,26]. Any conserved residues on the out- 
side of a surface helix will disrupt this approach 
since it undermines the initial premise that con- 
served residues reside on the inside. Placement of 
these three aromatic residues on the outside in our 
model (fig.5) would result in the movement of the 
proline residues in all three of these helices towards 
the inner face. These three proline residues, which 
lie at a similar depth in our model (fig.6), have been 
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Fig.7. The sequence alignment for the third putative membrane spanning region. This region is thought to be important in directly 
binding ligand. 
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postulated to be important in distorting the struc- 
ture to allow for ligand binding [7,55,57]. 
We believe that the theoretical method outlined 
above allows a good ‘first approximation’ in the 
study of the structure of this class of receptors 
which can then be adapted to take into account the 
experimental evidence available. 
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